

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | fatty acid transmembrane transport (GO:1902001) | 5.16324763 |
| 2 | valine metabolic process (GO:0006573) | 5.12601389 |
| 3 | carnitine shuttle (GO:0006853) | 5.10180850 |
| 4 | regulation of sequestering of triglyceride (GO:0010889) | 5.04967134 |
| 5 | alpha-linolenic acid metabolic process (GO:0036109) | 4.92395945 |
| 6 | low-density lipoprotein particle clearance (GO:0034383) | 4.82231921 |
| 7 | * positive regulation of fatty acid beta-oxidation (GO:0032000) | 4.60482691 |
| 8 | biotin metabolic process (GO:0006768) | 4.52184320 |
| 9 | fatty acid beta-oxidation (GO:0006635) | 4.49092375 |
| 10 | 2-oxoglutarate metabolic process (GO:0006103) | 4.47692181 |
| 11 | negative regulation of erythrocyte differentiation (GO:0045647) | 4.44954250 |
| 12 | lysine catabolic process (GO:0006554) | 4.44100963 |
| 13 | lysine metabolic process (GO:0006553) | 4.44100963 |
| 14 | * positive regulation of fatty acid oxidation (GO:0046321) | 4.35726201 |
| 15 | * regulation of fatty acid oxidation (GO:0046320) | 4.29667068 |
| 16 | * regulation of fatty acid beta-oxidation (GO:0031998) | 4.25410146 |
| 17 | tricarboxylic acid metabolic process (GO:0072350) | 4.14980140 |
| 18 | mannose metabolic process (GO:0006013) | 4.11778498 |
| 19 | carnitine transmembrane transport (GO:1902603) | 4.02020307 |
| 20 | fatty acid oxidation (GO:0019395) | 4.00722021 |
| 21 | focal adhesion assembly (GO:0048041) | 3.96924794 |
| 22 | cell-substrate adherens junction assembly (GO:0007045) | 3.96924794 |
| 23 | lipid oxidation (GO:0034440) | 3.96550208 |
| 24 | acetyl-CoA metabolic process (GO:0006084) | 3.92294774 |
| 25 | triglyceride catabolic process (GO:0019433) | 3.92177030 |
| 26 | sulfur amino acid catabolic process (GO:0000098) | 3.85351237 |
| 27 | fatty acid catabolic process (GO:0009062) | 3.84231870 |
| 28 | adherens junction assembly (GO:0034333) | 3.83722765 |
| 29 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.80691244 |
| 30 | regulation of cholesterol storage (GO:0010885) | 3.78385303 |
| 31 | neutral lipid catabolic process (GO:0046461) | 3.78252633 |
| 32 | acylglycerol catabolic process (GO:0046464) | 3.78252633 |
| 33 | amino-acid betaine transport (GO:0015838) | 3.77536019 |
| 34 | carnitine transport (GO:0015879) | 3.77536019 |
| 35 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.74595909 |
| 36 | tricarboxylic acid cycle (GO:0006099) | 3.67445156 |
| 37 | regulation of cholesterol homeostasis (GO:2000188) | 3.67437037 |
| 38 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.67363165 |
| 39 | regulation of triglyceride catabolic process (GO:0010896) | 3.66763179 |
| 40 | positive regulation of triglyceride metabolic process (GO:0090208) | 3.61819896 |
| 41 | positive regulation of triglyceride biosynthetic process (GO:0010867) | 3.61051485 |
| 42 | branched-chain amino acid metabolic process (GO:0009081) | 3.54363309 |
| 43 | positive regulation of histone deacetylation (GO:0031065) | 3.52456712 |
| 44 | carnitine metabolic process (GO:0009437) | 3.51817572 |
| 45 | amino-acid betaine metabolic process (GO:0006577) | 3.50880451 |
| 46 | regulation of triglyceride biosynthetic process (GO:0010866) | 3.49145272 |
| 47 | fatty acid homeostasis (GO:0055089) | 3.46932294 |
| 48 | plasma lipoprotein particle clearance (GO:0034381) | 3.45210465 |
| 49 | oxaloacetate metabolic process (GO:0006107) | 3.44277533 |
| 50 | apoptotic process involved in morphogenesis (GO:0060561) | 3.42925291 |
| 51 | aspartate family amino acid catabolic process (GO:0009068) | 3.38464270 |
| 52 | monocarboxylic acid catabolic process (GO:0072329) | 3.38054467 |
| 53 | branched-chain amino acid catabolic process (GO:0009083) | 3.36429762 |
| 54 | * positive regulation of lipid catabolic process (GO:0050996) | 3.35144887 |
| 55 | ethanol oxidation (GO:0006069) | 3.33691606 |
| 56 | regulation of NFAT protein import into nucleus (GO:0051532) | 3.32552608 |
| 57 | intracellular estrogen receptor signaling pathway (GO:0030520) | 3.32153450 |
| 58 | regulation of histone H3-K27 methylation (GO:0061085) | 3.30695102 |
| 59 | complement activation, alternative pathway (GO:0006957) | 3.29561350 |
| 60 | cysteine metabolic process (GO:0006534) | 3.24618351 |
| 61 | insulin-like growth factor receptor signaling pathway (GO:0048009) | 3.23994141 |
| 62 | regulation of chromatin binding (GO:0035561) | 3.22004509 |
| 63 | short-chain fatty acid metabolic process (GO:0046459) | 3.21744599 |
| 64 | L-phenylalanine metabolic process (GO:0006558) | 3.20907201 |
| 65 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.20907201 |
| 66 | regulation of triglyceride metabolic process (GO:0090207) | 3.18959390 |
| 67 | growth hormone receptor signaling pathway (GO:0060396) | 3.18798823 |
| 68 | white fat cell differentiation (GO:0050872) | 3.17683265 |
| 69 | thioester biosynthetic process (GO:0035384) | 3.15255117 |
| 70 | acyl-CoA biosynthetic process (GO:0071616) | 3.15255117 |
| 71 | * positive regulation of fatty acid metabolic process (GO:0045923) | 3.15243677 |
| 72 | positive regulation of lipid storage (GO:0010884) | 3.15146981 |
| 73 | activation of Rac GTPase activity (GO:0032863) | 3.14434109 |
| 74 | creatine metabolic process (GO:0006600) | 3.09816849 |
| 75 | negative regulation of myotube differentiation (GO:0010832) | 3.09706119 |
| 76 | cell-substrate junction assembly (GO:0007044) | 3.09455834 |
| 77 | NADH metabolic process (GO:0006734) | 3.08901216 |
| 78 | positive regulation of myotube differentiation (GO:0010831) | 3.08527255 |
| 79 | L-phenylalanine catabolic process (GO:0006559) | 3.05616255 |
| 80 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.05616255 |
| 81 | 4-hydroxyproline metabolic process (GO:0019471) | 3.05592830 |
| 82 | histone H3-K36 demethylation (GO:0070544) | 3.03795076 |
| 83 | thymic T cell selection (GO:0045061) | 3.02985921 |
| 84 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 3.02638941 |
| 85 | brown fat cell differentiation (GO:0050873) | 3.02509315 |
| 86 | negative regulation of cell size (GO:0045792) | 3.02267262 |
| 87 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 3.00877626 |
| 88 | cellular response to virus (GO:0098586) | 3.00615220 |
| 89 | cellular modified amino acid catabolic process (GO:0042219) | 2.99204008 |
| 90 | positive regulation of transcription from RNA polymerase III promoter (GO:0045945) | 2.98904629 |
| 91 | glyoxylate metabolic process (GO:0046487) | 2.98636375 |
| 92 | negative regulation of fatty acid biosynthetic process (GO:0045717) | 2.98306616 |
| 93 | planar cell polarity pathway involved in neural tube closure (GO:0090179) | 2.98233139 |
| 94 | intracellular lipid transport (GO:0032365) | 2.97254373 |
| 95 | maternal placenta development (GO:0001893) | 2.95498674 |
| 96 | acylglycerol homeostasis (GO:0055090) | 2.95041060 |
| 97 | triglyceride homeostasis (GO:0070328) | 2.95041060 |
| 98 | modulation by symbiont of host cellular process (GO:0044068) | 2.94277809 |
| 99 | quaternary ammonium group transport (GO:0015697) | 2.90778586 |
| 100 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 2.90066838 |
| 101 | triglyceride metabolic process (GO:0006641) | 2.89869166 |
| 102 | cellular response to growth hormone stimulus (GO:0071378) | 2.88365799 |
| 103 | regulation of cholesterol metabolic process (GO:0090181) | 2.87970761 |
| 104 | peptidyl-glutamic acid carboxylation (GO:0017187) | 2.86615568 |
| 105 | protein carboxylation (GO:0018214) | 2.86615568 |
| 106 | positive thymic T cell selection (GO:0045059) | 2.85871052 |
| 107 | apoptotic cell clearance (GO:0043277) | 2.84675856 |
| 108 | phospholipid homeostasis (GO:0055091) | 2.83599344 |
| 109 | regulation of mammary gland epithelial cell proliferation (GO:0033599) | 2.83174190 |
| 110 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S tr | 2.82622405 |
| 111 | negative regulation of viral release from host cell (GO:1902187) | 2.82217574 |
| 112 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.81876360 |
| 113 | succinate metabolic process (GO:0006105) | 2.80995653 |
| 114 | * regulation of fatty acid metabolic process (GO:0019217) | 2.80172989 |
| 115 | modulation by virus of host process (GO:0019054) | 2.79875882 |
| 116 | lipid particle organization (GO:0034389) | 2.79282825 |
| 117 | positive regulation of protein deacetylation (GO:0090312) | 2.79170366 |
| 118 | acylglycerol metabolic process (GO:0006639) | 2.77845277 |
| 119 | semaphorin-plexin signaling pathway (GO:0071526) | 2.77786060 |
| 120 | homocysteine metabolic process (GO:0050667) | 2.77275029 |
| 121 | actin-myosin filament sliding (GO:0033275) | 2.76468451 |
| 122 | muscle filament sliding (GO:0030049) | 2.76468451 |
| 123 | serine family amino acid catabolic process (GO:0009071) | 2.75249081 |
| 124 | regulation of ARF protein signal transduction (GO:0032012) | 2.75081002 |
| 125 | triglyceride biosynthetic process (GO:0019432) | 2.72788445 |
| 126 | response to laminar fluid shear stress (GO:0034616) | 2.71350121 |
| 127 | neutral lipid metabolic process (GO:0006638) | 2.70874174 |
| 128 | regulation of early endosome to late endosome transport (GO:2000641) | 2.70728217 |
| 129 | regulation of fatty acid biosynthetic process (GO:0042304) | 2.70510787 |
| 130 | activation of JUN kinase activity (GO:0007257) | 2.70353540 |
| 131 | positive regulation of CREB transcription factor activity (GO:0032793) | 2.69028225 |
| 132 | fatty-acyl-CoA biosynthetic process (GO:0046949) | 2.68965378 |
| 133 | regulation of skeletal muscle contraction (GO:0014819) | 2.68924427 |
| 134 | negative regulation of fibrinolysis (GO:0051918) | 2.68713792 |
| 135 | carboxylic acid catabolic process (GO:0046395) | 2.68607373 |
| 136 | organic acid catabolic process (GO:0016054) | 2.68607373 |
| 137 | positive regulation of blood vessel endothelial cell migration (GO:0043536) | 2.67278948 |
| 138 | regulation of establishment of planar polarity involved in neural tube closure (GO:0090178) | 2.65682870 |
| 139 | embryonic process involved in female pregnancy (GO:0060136) | 2.64258979 |
| 140 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.59893620 |
| 141 | striated muscle atrophy (GO:0014891) | 2.59680683 |
| 142 | * regulation of glucose import in response to insulin stimulus (GO:2001273) | 2.59357445 |
| 143 | protein localization to endosome (GO:0036010) | 2.59249748 |
| 144 | regulation of necroptotic process (GO:0060544) | 2.58956817 |
| 145 | basement membrane organization (GO:0071711) | 2.57520592 |
| 146 | positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:00360 | 2.57134808 |
| 147 | protein targeting to plasma membrane (GO:0072661) | 2.56916107 |
| 148 | regulation of apoptotic process involved in morphogenesis (GO:1902337) | 2.56596555 |
| 149 | endothelial cell chemotaxis (GO:0035767) | 2.56572691 |
| 150 | skeletal muscle adaptation (GO:0043501) | 2.56308644 |
| 151 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.50851923 |
| 152 | cellular response to epidermal growth factor stimulus (GO:0071364) | 2.48468596 |
| 153 | RNA stabilization (GO:0043489) | 2.46860903 |
| 154 | mRNA stabilization (GO:0048255) | 2.46860903 |
| 155 | activation of MAPKKK activity (GO:0000185) | 2.46025221 |
| 156 | modulation by virus of host morphology or physiology (GO:0019048) | 2.45922196 |
| 157 | negative regulation of striated muscle cell differentiation (GO:0051154) | 2.45183713 |
| 158 | spliceosomal tri-snRNP complex assembly (GO:0000244) | 2.41202517 |
| 159 | regulation of histone deacetylation (GO:0031063) | 2.40640233 |
| 160 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.40248283 |
| 161 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.38980168 |
| 162 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 2.38514702 |
| 163 | cell-cell junction maintenance (GO:0045217) | 2.38029300 |
| 164 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.37994294 |
| 165 | glucocorticoid receptor signaling pathway (GO:0042921) | 2.37540081 |
| 166 | signal complex assembly (GO:0007172) | 2.37397188 |
| 167 | regulation of ARF GTPase activity (GO:0032312) | 2.37088057 |
| 168 | embryonic eye morphogenesis (GO:0048048) | 2.35989176 |
| 169 | peptidyl-lysine dimethylation (GO:0018027) | 2.34629374 |
| 170 | stress fiber assembly (GO:0043149) | 2.34545000 |
| 171 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.33476833 |
| 172 | histone H4 deacetylation (GO:0070933) | 2.33302228 |
| 173 | positive regulation of gene expression, epigenetic (GO:0045815) | 2.31414202 |
| 174 | epithelial cell-cell adhesion (GO:0090136) | 2.30728358 |
| 175 | regulation of nucleobase-containing compound transport (GO:0032239) | 2.30072975 |
| 176 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.29912160 |
| 177 | apoptotic process involved in development (GO:1902742) | 2.29752835 |
| 178 | proline biosynthetic process (GO:0006561) | 2.27347766 |
| 179 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 2.25695491 |
| 180 | SMAD protein complex assembly (GO:0007183) | 2.24866984 |
| 181 | histone lysine demethylation (GO:0070076) | 2.24772297 |
| 182 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.23996792 |
| 183 | negative regulation of cell killing (GO:0031342) | 2.23996792 |
| 184 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 2.23771689 |
| 185 | T cell selection (GO:0045058) | 2.23592784 |
| 186 | regulation of gamma-delta T cell activation (GO:0046643) | 2.23580893 |
| 187 | negative regulation of necroptotic process (GO:0060546) | 2.23504843 |
| 188 | positive regulation of extracellular matrix organization (GO:1903055) | 2.23118888 |
| 189 | negative regulation of phosphatidylinositol 3-kinase signaling (GO:0014067) | 2.23028179 |
| 190 | atrioventricular valve morphogenesis (GO:0003181) | 2.22228509 |
| 191 | osteoblast development (GO:0002076) | 2.21439096 |
| 192 | positive regulation of protein dephosphorylation (GO:0035307) | 2.18499043 |
| 193 | negative regulation of skeletal muscle tissue development (GO:0048642) | 2.16921836 |
| 194 | embryonic camera-type eye morphogenesis (GO:0048596) | 2.16543700 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 7.53927579 |
| 2 | * ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 5.73175264 |
| 3 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 4.34388400 |
| 4 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 4.10420198 |
| 5 | * TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 3.84552788 |
| 6 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 3.58683286 |
| 7 | CLOCK_20551151_ChIP-Seq_293T_Human | 3.34419534 |
| 8 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.80108279 |
| 9 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.77962727 |
| 10 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.54191520 |
| 11 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.49455080 |
| 12 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.43336485 |
| 13 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 2.40959559 |
| 14 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.15733597 |
| 15 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.12933141 |
| 16 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.06318643 |
| 17 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 2.01127710 |
| 18 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.89629153 |
| 19 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.86063247 |
| 20 | MYC_22102868_ChIP-Seq_BL_Human | 1.81528934 |
| 21 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.77844874 |
| 22 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.76790446 |
| 23 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.76040046 |
| 24 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.76040046 |
| 25 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.75871503 |
| 26 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.73345123 |
| 27 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.68699438 |
| 28 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.66682971 |
| 29 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 1.62955434 |
| 30 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.59213941 |
| 31 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.57692430 |
| 32 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.57013378 |
| 33 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.56918643 |
| 34 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.54004538 |
| 35 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.53576181 |
| 36 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.50409342 |
| 37 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 1.48560703 |
| 38 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.48319338 |
| 39 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.47364013 |
| 40 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.47356704 |
| 41 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.44203601 |
| 42 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.43207948 |
| 43 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.41728211 |
| 44 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.39512641 |
| 45 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.38988640 |
| 46 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.38920202 |
| 47 | ATF3_27146783_Chip-Seq_COLON_Human | 1.34007382 |
| 48 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.31870476 |
| 49 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.31085925 |
| 50 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.28817822 |
| 51 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.27553218 |
| 52 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.26394544 |
| 53 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.26160913 |
| 54 | MAF_26560356_Chip-Seq_TH1_Human | 1.25704157 |
| 55 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.23701349 |
| 56 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.22754505 |
| 57 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.22109798 |
| 58 | * CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.22037723 |
| 59 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.21911517 |
| 60 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.20594918 |
| 61 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.18148029 |
| 62 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 1.17684565 |
| 63 | KDM2B_26808549_Chip-Seq_K562_Human | 1.17348838 |
| 64 | * TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.17106741 |
| 65 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.16644667 |
| 66 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.16186629 |
| 67 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.16088550 |
| 68 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.15900892 |
| 69 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.14902220 |
| 70 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 1.14632668 |
| 71 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 1.14151822 |
| 72 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.14039344 |
| 73 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.13831394 |
| 74 | GATA1_19941826_ChIP-Seq_K562_Human | 1.12954745 |
| 75 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.12804349 |
| 76 | GATA1_22025678_ChIP-Seq_K562_Human | 1.12729939 |
| 77 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.12426419 |
| 78 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.12032652 |
| 79 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.11014567 |
| 80 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.11001382 |
| 81 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.09535354 |
| 82 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.08900689 |
| 83 | P68_20966046_ChIP-Seq_HELA_Human | 1.08414610 |
| 84 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.07922076 |
| 85 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.07193129 |
| 86 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.07082696 |
| 87 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.06813368 |
| 88 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.05012728 |
| 89 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.02153467 |
| 90 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.02074810 |
| 91 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.01702087 |
| 92 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.01495126 |
| 93 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.01182759 |
| 94 | UTX_26944678_Chip-Seq_JUKART_Human | 1.00840696 |
| 95 | TFAP2A_17053090_ChIP-ChIP_MCF-7_Human | 1.00632623 |
| 96 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.00435080 |
| 97 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.00133329 |
| 98 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.99922600 |
| 99 | CTCF_21964334_Chip-Seq_Bcells_Human | 0.99279304 |
| 100 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 0.98551500 |
| 101 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.98285433 |
| 102 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.97605071 |
| 103 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.97357693 |
| 104 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.97094476 |
| 105 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.96513636 |
| 106 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.95816206 |
| 107 | SCL_19346495_ChIP-Seq_HPC-7_Human | 0.95351724 |
| 108 | * BCL6_27268052_Chip-Seq_Bcells_Human | 0.95175246 |
| 109 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.95082600 |
| 110 | PKCTHETA_26484144_Chip-Seq_BREAST_Human | 0.93839465 |
| 111 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 0.93720663 |
| 112 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 0.93700167 |
| 113 | * NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 0.93330569 |
| 114 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.93049428 |
| 115 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.92177810 |
| 116 | * BCOR_27268052_Chip-Seq_Bcells_Human | 0.90133389 |
| 117 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.90064790 |
| 118 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.89255063 |
| 119 | TP63_22573176_ChIP-Seq_HFKS_Human | 0.88274155 |
| 120 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.88158724 |
| 121 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.88088054 |
| 122 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 0.87632649 |
| 123 | * DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.84257544 |
| 124 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.83871849 |
| 125 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.83814396 |
| 126 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.83336472 |
| 127 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.82628557 |
| 128 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.82446202 |
| 129 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.82375246 |
| 130 | MAF_26560356_Chip-Seq_TH2_Human | 0.82289400 |
| 131 | * SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.80841610 |
| 132 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.80555396 |
| 133 | VDR_24763502_ChIP-Seq_THP-1_Human | 0.80462366 |
| 134 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.79221302 |
| 135 | * SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.78945677 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005451_abnormal_body_composition | 3.87960395 |
| 2 | MP0005670_abnormal_white_adipose | 3.84171766 |
| 3 | MP0002139_abnormal_hepatobiliary_system | 3.54729745 |
| 4 | MP0003705_abnormal_hypodermis_morpholog | 3.53807551 |
| 5 | MP0002837_dystrophic_cardiac_calcinosis | 3.28877482 |
| 6 | * MP0004130_abnormal_muscle_cell | 3.25299100 |
| 7 | * MP0005666_abnormal_adipose_tissue | 2.98244850 |
| 8 | MP0005365_abnormal_bile_salt | 2.98019760 |
| 9 | MP0005360_urolithiasis | 2.71793982 |
| 10 | MP0008438_abnormal_cutaneous_collagen | 2.64918351 |
| 11 | MP0010329_abnormal_lipoprotein_level | 2.57309234 |
| 12 | MP0003646_muscle_fatigue | 2.55719071 |
| 13 | MP0000751_myopathy | 2.53120226 |
| 14 | * MP0004185_abnormal_adipocyte_glucose | 2.44317080 |
| 15 | * MP0005375_adipose_tissue_phenotype | 2.25048268 |
| 16 | MP0009840_abnormal_foam_cell | 2.20027590 |
| 17 | MP0005085_abnormal_gallbladder_physiolo | 2.19071406 |
| 18 | MP0002249_abnormal_larynx_morphology | 2.13457371 |
| 19 | * MP0002971_abnormal_brown_adipose | 2.05817161 |
| 20 | MP0004858_abnormal_nervous_system | 2.04900909 |
| 21 | MP0003191_abnormal_cellular_cholesterol | 2.01040482 |
| 22 | MP0004087_abnormal_muscle_fiber | 2.00578064 |
| 23 | MP0003436_decreased_susceptibility_to | 1.88528716 |
| 24 | MP0000749_muscle_degeneration | 1.87121277 |
| 25 | MP0004084_abnormal_cardiac_muscle | 1.82792777 |
| 26 | MP0005275_abnormal_skin_tensile | 1.79762630 |
| 27 | * MP0002118_abnormal_lipid_homeostasis | 1.78582207 |
| 28 | MP0000013_abnormal_adipose_tissue | 1.78054361 |
| 29 | MP0000003_abnormal_adipose_tissue | 1.77501273 |
| 30 | MP0003763_abnormal_thymus_physiology | 1.77141834 |
| 31 | MP0001348_abnormal_lacrimal_gland | 1.74114202 |
| 32 | MP0005409_darkened_coat_color | 1.73704017 |
| 33 | MP0005330_cardiomyopathy | 1.73302515 |
| 34 | MP0009278_abnormal_bone_marrow | 1.73111968 |
| 35 | MP0003091_abnormal_cell_migration | 1.71778047 |
| 36 | MP0000750_abnormal_muscle_regeneration | 1.70247894 |
| 37 | MP0001873_stomach_inflammation | 1.69652521 |
| 38 | * MP0000609_abnormal_liver_physiology | 1.66790880 |
| 39 | MP0003252_abnormal_bile_duct | 1.65476964 |
| 40 | MP0001849_ear_inflammation | 1.64592751 |
| 41 | MP0000678_abnormal_parathyroid_gland | 1.62364001 |
| 42 | MP0003453_abnormal_keratinocyte_physiol | 1.60368734 |
| 43 | MP0002269_muscular_atrophy | 1.58669469 |
| 44 | MP0004036_abnormal_muscle_relaxation | 1.58266806 |
| 45 | MP0003806_abnormal_nucleotide_metabolis | 1.58259321 |
| 46 | MP0008961_abnormal_basal_metabolism | 1.55010549 |
| 47 | MP0000747_muscle_weakness | 1.54902780 |
| 48 | MP0009115_abnormal_fat_cell | 1.53838356 |
| 49 | MP0004947_skin_inflammation | 1.52429049 |
| 50 | MP0003566_abnormal_cell_adhesion | 1.52374909 |
| 51 | MP0008260_abnormal_autophagy | 1.51795421 |
| 52 | MP0005332_abnormal_amino_acid | 1.50533542 |
| 53 | MP0000759_abnormal_skeletal_muscle | 1.49150783 |
| 54 | MP0000681_abnormal_thyroid_gland | 1.44528005 |
| 55 | MP0010630_abnormal_cardiac_muscle | 1.41915962 |
| 56 | MP0005334_abnormal_fat_pad | 1.41585124 |
| 57 | MP0003300_gastrointestinal_ulcer | 1.41120800 |
| 58 | MP0000537_abnormal_urethra_morphology | 1.40741026 |
| 59 | MP0008875_abnormal_xenobiotic_pharmacok | 1.37264914 |
| 60 | MP0005319_abnormal_enzyme/_coenzyme | 1.33417242 |
| 61 | MP0002106_abnormal_muscle_physiology | 1.32577303 |
| 62 | MP0005083_abnormal_biliary_tract | 1.31690660 |
| 63 | MP0009333_abnormal_splenocyte_physiolog | 1.31483464 |
| 64 | MP0000685_abnormal_immune_system | 1.30942655 |
| 65 | MP0002009_preneoplasia | 1.29674882 |
| 66 | MP0001544_abnormal_cardiovascular_syste | 1.29010468 |
| 67 | MP0005385_cardiovascular_system_phenoty | 1.29010468 |
| 68 | MP0004381_abnormal_hair_follicle | 1.26707732 |
| 69 | MP0003279_aneurysm | 1.26221369 |
| 70 | MP0002089_abnormal_postnatal_growth/wei | 1.25633372 |
| 71 | MP0005620_abnormal_muscle_contractility | 1.25116179 |
| 72 | MP0004233_abnormal_muscle_weight | 1.24400001 |
| 73 | MP0003172_abnormal_lysosome_physiology | 1.24256516 |
| 74 | MP0000858_altered_metastatic_potential | 1.23689900 |
| 75 | MP0004215_abnormal_myocardial_fiber | 1.23659012 |
| 76 | MP0006138_congestive_heart_failure | 1.22909394 |
| 77 | * MP0002970_abnormal_white_adipose | 1.22029911 |
| 78 | MP0005503_abnormal_tendon_morphology | 1.21730162 |
| 79 | MP0000733_abnormal_muscle_development | 1.21306371 |
| 80 | MP0002396_abnormal_hematopoietic_system | 1.20701486 |
| 81 | MP0006036_abnormal_mitochondrial_physio | 1.14258424 |
| 82 | MP0008775_abnormal_heart_ventricle | 1.12508159 |
| 83 | MP0005076_abnormal_cell_differentiation | 1.12501063 |
| 84 | MP0002972_abnormal_cardiac_muscle | 1.09202644 |
| 85 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.08924139 |
| 86 | MP0003221_abnormal_cardiomyocyte_apopto | 1.08268109 |
| 87 | MP0002909_abnormal_adrenal_gland | 1.06955981 |
| 88 | MP0001666_abnormal_nutrient_absorption | 1.06471692 |
| 89 | MP0005369_muscle_phenotype | 1.05445468 |
| 90 | * MP0002078_abnormal_glucose_homeostasis | 1.05169322 |
| 91 | MP0004808_abnormal_hematopoietic_stem | 1.02914690 |
| 92 | MP0003879_abnormal_hair_cell | 1.02099082 |
| 93 | MP0009384_cardiac_valve_regurgitation | 1.01455282 |
| 94 | MP0001661_extended_life_span | 0.97719623 |
| 95 | MP0009643_abnormal_urine_homeostasis | 0.96001548 |
| 96 | MP0000703_abnormal_thymus_morphology | 0.95214062 |
| 97 | MP0005535_abnormal_body_temperature | 0.94249996 |
| 98 | MP0004145_abnormal_muscle_electrophysio | 0.91204362 |
| 99 | MP0003828_pulmonary_edema | 0.89740190 |
| 100 | MP0001730_embryonic_growth_arrest | 0.88364515 |
| 101 | MP0002933_joint_inflammation | 0.87729511 |
| 102 | MP0009780_abnormal_chondrocyte_physiolo | 0.87556213 |
| 103 | MP0000343_altered_response_to | 0.87494552 |
| 104 | MP0003329_amyloid_beta_deposits | 0.86984167 |
| 105 | MP0002060_abnormal_skin_morphology | 0.86821116 |
| 106 | MP0005058_abnormal_lysosome_morphology | 0.84765576 |
| 107 | MP0002254_reproductive_system_inflammat | 0.84613956 |
| 108 | MP0002166_altered_tumor_susceptibility | 0.84057012 |
| 109 | MP0004272_abnormal_basement_membrane | 0.83453162 |
| 110 | MP0000598_abnormal_liver_morphology | 0.82923646 |
| 111 | MP0005501_abnormal_skin_physiology | 0.81994443 |
| 112 | MP0003959_abnormal_lean_body | 0.81929924 |
| 113 | MP0002877_abnormal_melanocyte_morpholog | 0.81486367 |
| 114 | MP0005621_abnormal_cell_physiology | 0.80443171 |
| 115 | MP0000767_abnormal_smooth_muscle | 0.80360855 |
| 116 | MP0002998_abnormal_bone_remodeling | 0.79753199 |
| 117 | MP0003303_peritoneal_inflammation | 0.79310555 |
| 118 | MP0009931_abnormal_skin_appearance | 0.78370389 |
| 119 | MP0005448_abnormal_energy_balance | 0.78169945 |
| 120 | MP0005023_abnormal_wound_healing | 0.77831326 |
| 121 | MP0005623_abnormal_meninges_morphology | 0.77164227 |
| 122 | MP0002796_impaired_skin_barrier | 0.76392113 |
| 123 | MP0003115_abnormal_respiratory_system | 0.75541135 |
| 124 | MP0002398_abnormal_bone_marrow | 0.75497649 |
| 125 | MP0010352_gastrointestinal_tract_polyps | 0.75369667 |
| 126 | MP0002108_abnormal_muscle_morphology | 0.74774299 |
| 127 | MP0001958_emphysema | 0.73918116 |
| 128 | MP0003186_abnormal_redox_activity | 0.73599187 |
| 129 | MP0003656_abnormal_erythrocyte_physiolo | 0.72723130 |
| 130 | MP0003942_abnormal_urinary_system | 0.71198756 |
| 131 | MP0001533_abnormal_skeleton_physiology | 0.69778759 |
| 132 | MP0009672_abnormal_birth_weight | 0.69587637 |
| 133 | MP0001800_abnormal_humoral_immune | 0.66997155 |
| 134 | MP0003045_fibrosis | 0.66293010 |
| 135 | MP0002128_abnormal_blood_circulation | 0.66292622 |
| 136 | MP0005387_immune_system_phenotype | 0.65371687 |
| 137 | MP0001790_abnormal_immune_system | 0.65371687 |
| 138 | MP0003195_calcinosis | 0.65058245 |
| 139 | MP0000266_abnormal_heart_morphology | 0.64197949 |
| 140 | MP0002925_abnormal_cardiovascular_devel | 0.63785345 |
| 141 | MP0001853_heart_inflammation | 0.63658146 |
| 142 | MP0000534_abnormal_ureter_morphology | 0.62930504 |
| 143 | MP0002332_abnormal_exercise_endurance | 0.62124428 |
| 144 | * MP0005452_abnormal_adipose_tissue | 0.60383251 |
| 145 | MP0004510_myositis | 0.59700626 |
| 146 | MP0003690_abnormal_glial_cell | 0.59655671 |
| 147 | MP0003137_abnormal_impulse_conducting | 0.59136810 |
| 148 | MP0002138_abnormal_hepatobiliary_system | 0.59038617 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Myoglobinuria (HP:0002913) | 4.53821520 |
| 2 | Exercise-induced myalgia (HP:0003738) | 4.27368371 |
| 3 | Increased connective tissue (HP:0009025) | 3.95747190 |
| 4 | Difficulty running (HP:0009046) | 3.79843390 |
| 5 | Hyperacusis (HP:0010780) | 3.75940420 |
| 6 | Hypoglycemic coma (HP:0001325) | 3.75656819 |
| 7 | Type 1 muscle fiber predominance (HP:0003803) | 3.70541900 |
| 8 | Hyperglycinuria (HP:0003108) | 3.65713920 |
| 9 | Obstructive sleep apnea (HP:0002870) | 3.64034698 |
| 10 | Ketoacidosis (HP:0001993) | 3.58992474 |
| 11 | Ketosis (HP:0001946) | 3.58605714 |
| 12 | Xanthomatosis (HP:0000991) | 3.58029941 |
| 13 | Hypoalphalipoproteinemia (HP:0003233) | 3.53687490 |
| 14 | Hyporeflexia of lower limbs (HP:0002600) | 3.51874923 |
| 15 | Rhabdomyolysis (HP:0003201) | 3.44132967 |
| 16 | Hyperammonemia (HP:0001987) | 3.33827406 |
| 17 | Deep venous thrombosis (HP:0002625) | 3.33024631 |
| 18 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.29777861 |
| 19 | Abnormality of glycine metabolism (HP:0010895) | 3.29777861 |
| 20 | Muscle fiber splitting (HP:0003555) | 3.28976332 |
| 21 | Exercise-induced muscle cramps (HP:0003710) | 3.22336217 |
| 22 | Broad face (HP:0000283) | 3.20869355 |
| 23 | Abnormality of the fingertips (HP:0001211) | 3.06161976 |
| 24 | Distal lower limb amyotrophy (HP:0008944) | 3.04726510 |
| 25 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.04577957 |
| 26 | Hyperlipoproteinemia (HP:0010980) | 2.95766705 |
| 27 | Sudden death (HP:0001699) | 2.87142201 |
| 28 | Complement deficiency (HP:0004431) | 2.81433722 |
| 29 | Dysmetric saccades (HP:0000641) | 2.75711277 |
| 30 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.74197481 |
| 31 | Myocardial infarction (HP:0001658) | 2.73770043 |
| 32 | Asymmetric septal hypertrophy (HP:0001670) | 2.72922133 |
| 33 | Protrusio acetabuli (HP:0003179) | 2.72526593 |
| 34 | Increased variability in muscle fiber diameter (HP:0003557) | 2.71058466 |
| 35 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.67449559 |
| 36 | Hypolipoproteinemia (HP:0010981) | 2.67127107 |
| 37 | Ulnar bowing (HP:0003031) | 2.61536655 |
| 38 | Hypertriglyceridemia (HP:0002155) | 2.60085252 |
| 39 | Muscle fiber inclusion bodies (HP:0100299) | 2.59812178 |
| 40 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 2.57127717 |
| 41 | Ventricular tachycardia (HP:0004756) | 2.56494673 |
| 42 | Hyperglycinemia (HP:0002154) | 2.56293170 |
| 43 | Cerebral aneurysm (HP:0004944) | 2.55814025 |
| 44 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.54200943 |
| 45 | Right ventricular cardiomyopathy (HP:0011663) | 2.53071223 |
| 46 | Difficulty climbing stairs (HP:0003551) | 2.52646402 |
| 47 | Round ear (HP:0100830) | 2.50488700 |
| 48 | Thin bony cortex (HP:0002753) | 2.50198198 |
| 49 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.49370626 |
| 50 | Atrioventricular block (HP:0001678) | 2.44921857 |
| 51 | Flat acetabular roof (HP:0003180) | 2.44199752 |
| 52 | Calf muscle hypertrophy (HP:0008981) | 2.41106414 |
| 53 | Ulnar deviation of the wrist (HP:0003049) | 2.36757742 |
| 54 | Dicarboxylic aciduria (HP:0003215) | 2.36234020 |
| 55 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.36234020 |
| 56 | Dislocated radial head (HP:0003083) | 2.33358032 |
| 57 | Lipoatrophy (HP:0100578) | 2.33322799 |
| 58 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.33042656 |
| 59 | Abnormality of the Achilles tendon (HP:0005109) | 2.31155987 |
| 60 | Polycythemia (HP:0001901) | 2.30392371 |
| 61 | Stridor (HP:0010307) | 2.29536926 |
| 62 | Oligomenorrhea (HP:0000876) | 2.29480052 |
| 63 | Distal lower limb muscle weakness (HP:0009053) | 2.27815417 |
| 64 | Vertebral compression fractures (HP:0002953) | 2.27711862 |
| 65 | Broad metatarsal (HP:0001783) | 2.27306453 |
| 66 | * Acanthosis nigricans (HP:0000956) | 2.23668518 |
| 67 | Muscle stiffness (HP:0003552) | 2.23252876 |
| 68 | Epidermoid cyst (HP:0200040) | 2.22988892 |
| 69 | Intrahepatic cholestasis (HP:0001406) | 2.22758413 |
| 70 | Abnormality of the radial head (HP:0003995) | 2.22482557 |
| 71 | Disproportionate tall stature (HP:0001519) | 2.22008350 |
| 72 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.20885362 |
| 73 | Rectal prolapse (HP:0002035) | 2.20857890 |
| 74 | Segmental peripheral demyelination/remyelination (HP:0003481) | 2.20111540 |
| 75 | EMG: myopathic abnormalities (HP:0003458) | 2.18255446 |
| 76 | Biconcave vertebral bodies (HP:0004586) | 2.18079000 |
| 77 | Muscle hypertrophy of the lower extremities (HP:0008968) | 2.17714428 |
| 78 | Abnormality of complement system (HP:0005339) | 2.17573360 |
| 79 | Achilles tendon contracture (HP:0001771) | 2.16939068 |
| 80 | Colitis (HP:0002583) | 2.16572370 |
| 81 | Abnormality of the calf musculature (HP:0001430) | 2.16313475 |
| 82 | Hyperglycemia (HP:0003074) | 2.16157272 |
| 83 | Persistence of primary teeth (HP:0006335) | 2.15587226 |
| 84 | Myopathic facies (HP:0002058) | 2.15119374 |
| 85 | Germ cell neoplasia (HP:0100728) | 2.14954433 |
| 86 | Ankle contracture (HP:0006466) | 2.14240514 |
| 87 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.13837812 |
| 88 | Abnormal cartilage morphology (HP:0002763) | 2.11651931 |
| 89 | Skin nodule (HP:0200036) | 2.11391141 |
| 90 | Mitral regurgitation (HP:0001653) | 2.11329499 |
| 91 | Premature rupture of membranes (HP:0001788) | 2.10404075 |
| 92 | Subaortic stenosis (HP:0001682) | 2.08901236 |
| 93 | Abnormality of the left ventricular outflow tract (HP:0011103) | 2.08901236 |
| 94 | Multiple enchondromatosis (HP:0005701) | 2.08842962 |
| 95 | Asymmetry of the thorax (HP:0001555) | 2.07876910 |
| 96 | Lower limb amyotrophy (HP:0007210) | 2.07752934 |
| 97 | Distal arthrogryposis (HP:0005684) | 2.07517873 |
| 98 | Nemaline bodies (HP:0003798) | 2.04356981 |
| 99 | Bronchomalacia (HP:0002780) | 2.03871515 |
| 100 | Sparse lateral eyebrow (HP:0005338) | 2.03650677 |
| 101 | Onion bulb formation (HP:0003383) | 1.99180922 |
| 102 | Abnormality of proline metabolism (HP:0010907) | 1.98105873 |
| 103 | Hydroxyprolinuria (HP:0003080) | 1.98105873 |
| 104 | Mitral valve prolapse (HP:0001634) | 1.97686578 |
| 105 | Abnormality of the distal phalanx of the thumb (HP:0009617) | 1.97164668 |
| 106 | Insulin-resistant diabetes mellitus (HP:0000831) | 1.96477965 |
| 107 | Aneurysm (HP:0002617) | 1.96431056 |
| 108 | Abnormal atrioventricular conduction (HP:0005150) | 1.95955008 |
| 109 | Lymphangioma (HP:0100764) | 1.95885310 |
| 110 | Abnormality of the thoracic spine (HP:0100711) | 1.94997040 |
| 111 | Back pain (HP:0003418) | 1.94955545 |
| 112 | Facial diplegia (HP:0001349) | 1.94399767 |
| 113 | Spinal rigidity (HP:0003306) | 1.94370595 |
| 114 | Easy fatigability (HP:0003388) | 1.94184890 |
| 115 | Heart block (HP:0012722) | 1.93277759 |
| 116 | Cervical subluxation (HP:0003308) | 1.92670730 |
| 117 | Emphysema (HP:0002097) | 1.92243360 |
| 118 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.90670128 |
| 119 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 1.90065138 |
| 120 | Abnormality of the common coagulation pathway (HP:0010990) | 1.90027113 |
| 121 | Conjunctival hamartoma (HP:0100780) | 1.87449575 |
| 122 | Bundle branch block (HP:0011710) | 1.87070464 |
| 123 | Syringomyelia (HP:0003396) | 1.85628145 |
| 124 | Spinal cord lesions (HP:0100561) | 1.85628145 |
| 125 | Dilated cardiomyopathy (HP:0001644) | 1.85302061 |
| 126 | Macroorchidism (HP:0000053) | 1.83865921 |
| 127 | Hypoplastic ischia (HP:0003175) | 1.83798162 |
| 128 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 1.83302337 |
| 129 | Cellulitis (HP:0100658) | 1.81833124 |
| 130 | Turricephaly (HP:0000262) | 1.81752413 |
| 131 | Slender build (HP:0001533) | 1.81607963 |
| 132 | Gout (HP:0001997) | 1.81345332 |
| 133 | Scapular winging (HP:0003691) | 1.80955412 |
| 134 | Eczematoid dermatitis (HP:0000976) | 1.80827690 |
| 135 | Hypoglycemic seizures (HP:0002173) | 1.80744657 |
| 136 | Aortic aneurysm (HP:0004942) | 1.80487147 |
| 137 | Long palpebral fissure (HP:0000637) | 1.80005338 |
| 138 | Progressive muscle weakness (HP:0003323) | 1.78813376 |
| 139 | Abnormality of the calcaneus (HP:0008364) | 1.78540011 |
| 140 | Distal upper limb amyotrophy (HP:0007149) | 1.77675572 |
| 141 | Upper limb amyotrophy (HP:0009129) | 1.77675572 |
| 142 | Hemorrhage of the eye (HP:0011885) | 1.77656186 |
| 143 | Frequent falls (HP:0002359) | 1.77623407 |
| 144 | Shallow orbits (HP:0000586) | 1.77162337 |
| 145 | Hypercortisolism (HP:0001578) | 1.75415514 |
| 146 | Bladder diverticulum (HP:0000015) | 1.73015577 |
| 147 | Blue sclerae (HP:0000592) | 1.72814190 |
| 148 | Renovascular hypertension (HP:0100817) | 1.72127113 |
| 149 | Fragile skin (HP:0001030) | 1.71539609 |
| 150 | Advanced eruption of teeth (HP:0006288) | 1.70136449 |
| 151 | Patellar dislocation (HP:0002999) | 1.69934993 |
| 152 | Increased IgE level (HP:0003212) | 1.69481893 |
| 153 | Thin ribs (HP:0000883) | 1.67955806 |
| 154 | Long eyelashes (HP:0000527) | 1.67889372 |
| 155 | Insomnia (HP:0100785) | 1.66968695 |
| 156 | Bowel incontinence (HP:0002607) | 1.66156348 |
| 157 | Bulbar palsy (HP:0001283) | 1.64646403 |
| 158 | Precocious puberty (HP:0000826) | 1.63969331 |
| 159 | Deep palmar crease (HP:0006191) | 1.63386616 |
| 160 | Pointed chin (HP:0000307) | 1.62707986 |
| 161 | Genu recurvatum (HP:0002816) | 1.61793293 |
| 162 | Arnold-Chiari malformation (HP:0002308) | 1.61598679 |
| 163 | Abnormality of the humeroradial joint (HP:0100744) | 1.59616499 |
| 164 | Reticulocytosis (HP:0001923) | 1.59509905 |
| 165 | Metaphyseal cupping (HP:0003021) | 1.58977588 |
| 166 | Heterotopia (HP:0002282) | 1.58110037 |
| 167 | Gastrointestinal inflammation (HP:0004386) | 1.58095290 |
| 168 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.57058021 |
| 169 | Short nail (HP:0001799) | 1.56438633 |
| 170 | Gastrointestinal stroma tumor (HP:0100723) | 1.56074595 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * TRIB3 | 4.83919790 |
| 2 | PKN2 | 3.63075114 |
| 3 | SIK1 | 3.31365619 |
| 4 | PRPF4B | 3.28399478 |
| 5 | BCKDK | 3.27127200 |
| 6 | TTN | 3.14567051 |
| 7 | ERN1 | 3.14534602 |
| 8 | SMG1 | 3.09517076 |
| 9 | FGFR4 | 2.42374327 |
| 10 | IRAK3 | 2.34757774 |
| 11 | EEF2K | 2.08147514 |
| 12 | RIPK1 | 2.06918487 |
| 13 | CAMK1D | 1.99884690 |
| 14 | PDGFRA | 1.97144622 |
| 15 | MAP3K10 | 1.91520278 |
| 16 | PHKG1 | 1.86340660 |
| 17 | PHKG2 | 1.86340660 |
| 18 | PDK4 | 1.83078947 |
| 19 | PDK3 | 1.83078947 |
| 20 | PTK6 | 1.71182146 |
| 21 | LMTK2 | 1.68123119 |
| 22 | MAP2K3 | 1.64000014 |
| 23 | DMPK | 1.57420632 |
| 24 | EPHB1 | 1.46207644 |
| 25 | FLT3 | 1.45381191 |
| 26 | CAMK1G | 1.37559501 |
| 27 | MARK2 | 1.35745707 |
| 28 | LRRK2 | 1.33078961 |
| 29 | OBSCN | 1.32710631 |
| 30 | FGFR3 | 1.28900099 |
| 31 | EPHA3 | 1.26687746 |
| 32 | ICK | 1.24297103 |
| 33 | SIK2 | 1.23574899 |
| 34 | PRKD3 | 1.22368490 |
| 35 | MAP3K13 | 1.20452665 |
| 36 | MAP3K3 | 1.18135397 |
| 37 | TAOK1 | 1.17605935 |
| 38 | EPHA2 | 1.17284558 |
| 39 | DDR2 | 1.17154136 |
| 40 | LATS1 | 1.11688793 |
| 41 | MAP3K7 | 1.07922483 |
| 42 | IRAK4 | 1.06144788 |
| 43 | MAPK11 | 1.03778427 |
| 44 | CDK6 | 1.03266063 |
| 45 | TYRO3 | 1.03131014 |
| 46 | RIPK4 | 1.02356298 |
| 47 | FGFR2 | 0.99757525 |
| 48 | PRKAA2 | 0.98110290 |
| 49 | MAP2K2 | 0.94820880 |
| 50 | NEK9 | 0.93641421 |
| 51 | MTOR | 0.91974578 |
| 52 | PIK3CG | 0.91557073 |
| 53 | JAK3 | 0.90214229 |
| 54 | JAK1 | 0.89204370 |
| 55 | TAOK2 | 0.87767825 |
| 56 | CAMKK1 | 0.87011929 |
| 57 | RPS6KA2 | 0.84145618 |
| 58 | NEK1 | 0.83592101 |
| 59 | TNK2 | 0.83105297 |
| 60 | MAP4K1 | 0.79663439 |
| 61 | RET | 0.79543152 |
| 62 | PRKCH | 0.79214552 |
| 63 | JAK2 | 0.78945715 |
| 64 | PRKD1 | 0.78717312 |
| 65 | * PDPK1 | 0.78586542 |
| 66 | PINK1 | 0.78429011 |
| 67 | ZAP70 | 0.78180192 |
| 68 | MAPKAPK3 | 0.76510862 |
| 69 | PDK2 | 0.76359633 |
| 70 | IRAK2 | 0.76229224 |
| 71 | BMX | 0.75797423 |
| 72 | PDGFRB | 0.75739400 |
| 73 | MAPK12 | 0.74528408 |
| 74 | TGFBR2 | 0.73440718 |
| 75 | PRKD2 | 0.73031915 |
| 76 | MELK | 0.72638791 |
| 77 | RPS6KL1 | 0.72147267 |
| 78 | RPS6KC1 | 0.72147267 |
| 79 | PRKAA1 | 0.71410665 |
| 80 | RPS6KB2 | 0.70643001 |
| 81 | CDK4 | 0.69321476 |
| 82 | MAP3K1 | 0.69315410 |
| 83 | FGFR1 | 0.68410311 |
| 84 | CDK8 | 0.67931307 |
| 85 | TBK1 | 0.67118811 |
| 86 | MUSK | 0.64456448 |
| 87 | INSRR | 0.64443326 |
| 88 | DYRK1B | 0.63717717 |
| 89 | TYK2 | 0.63320856 |
| 90 | MAP2K1 | 0.61058745 |
| 91 | RPS6KA6 | 0.60608018 |
| 92 | BLK | 0.60597491 |
| 93 | CSK | 0.59923033 |
| 94 | MAP3K14 | 0.59683159 |
| 95 | PTK2 | 0.57381788 |
| 96 | MAP3K2 | 0.56844627 |
| 97 | MAP3K11 | 0.54454423 |
| 98 | CDK12 | 0.54331893 |
| 99 | LATS2 | 0.53469515 |
| 100 | CDK9 | 0.52282808 |
| 101 | STK10 | 0.51782240 |
| 102 | MET | 0.51237482 |
| 103 | SGK3 | 0.51223363 |
| 104 | PAK2 | 0.50293008 |
| 105 | CHUK | 0.49646917 |
| 106 | BTK | 0.48738521 |
| 107 | GSK3A | 0.48388996 |
| 108 | MAP3K6 | 0.48220576 |
| 109 | MST1R | 0.48176532 |
| 110 | NME2 | 0.47755112 |
| 111 | CDK7 | 0.46984439 |
| 112 | * PDK1 | 0.45449908 |
| 113 | MAP3K5 | 0.44030063 |
| 114 | GRK6 | 0.43368407 |
| 115 | KSR2 | 0.42828962 |
| 116 | TIE1 | 0.42201810 |
| 117 | STK38 | 0.42126612 |
| 118 | PAK4 | 0.41941186 |
| 119 | RPS6KA4 | 0.41343598 |
| 120 | BRD4 | 0.40427831 |
| 121 | AKT2 | 0.39319847 |
| 122 | FER | 0.38005376 |
| 123 | TRPM7 | 0.37398776 |
| 124 | CAMK4 | 0.37256155 |
| 125 | WNK1 | 0.36815098 |
| 126 | MAPK7 | 0.36793913 |
| 127 | PRKACG | 0.36378740 |
| 128 | RPS6KA1 | 0.35777778 |
| 129 | IRAK1 | 0.35756016 |
| 130 | HIPK2 | 0.35436363 |
| 131 | EPHB2 | 0.33832117 |
| 132 | MAP3K8 | 0.33605190 |
| 133 | ALK | 0.33336376 |
| 134 | STK24 | 0.32668915 |
| 135 | BRAF | 0.32640417 |
| 136 | ITK | 0.32631422 |
| 137 | NLK | 0.32517972 |
| 138 | CDC42BPA | 0.31533039 |
| 139 | STK3 | 0.31303863 |
| 140 | KDR | 0.30809864 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.74363717 |
| 2 | Fatty acid degradation_Homo sapiens_hsa00071 | 3.49229283 |
| 3 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 3.30202393 |
| 4 | Propanoate metabolism_Homo sapiens_hsa00640 | 3.29399158 |
| 5 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 3.21198878 |
| 6 | Fatty acid metabolism_Homo sapiens_hsa01212 | 3.09770512 |
| 7 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 3.00293236 |
| 8 | PPAR signaling pathway_Homo sapiens_hsa03320 | 2.89548490 |
| 9 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 2.64286040 |
| 10 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.56598759 |
| 11 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.55076209 |
| 12 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.20443932 |
| 13 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.03918878 |
| 14 | Carbon metabolism_Homo sapiens_hsa01200 | 2.02283485 |
| 15 | * Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.98259703 |
| 16 | Other glycan degradation_Homo sapiens_hsa00511 | 1.93071044 |
| 17 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.86512008 |
| 18 | * B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.86243636 |
| 19 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.85079622 |
| 20 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.73235588 |
| 21 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.66729140 |
| 22 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.60107612 |
| 23 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.59595696 |
| 24 | * Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.58461946 |
| 25 | * Pancreatic cancer_Homo sapiens_hsa05212 | 1.57256817 |
| 26 | * Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.56408745 |
| 27 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.52889108 |
| 28 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.49560712 |
| 29 | * Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.45940282 |
| 30 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.43455056 |
| 31 | * Renal cell carcinoma_Homo sapiens_hsa05211 | 1.40354647 |
| 32 | * Insulin resistance_Homo sapiens_hsa04931 | 1.39249197 |
| 33 | Peroxisome_Homo sapiens_hsa04146 | 1.37925533 |
| 34 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.37787333 |
| 35 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.36839146 |
| 36 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.33916912 |
| 37 | * Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.33067628 |
| 38 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.31699283 |
| 39 | Lysine degradation_Homo sapiens_hsa00310 | 1.31593876 |
| 40 | Thyroid cancer_Homo sapiens_hsa05216 | 1.31145781 |
| 41 | * ErbB signaling pathway_Homo sapiens_hsa04012 | 1.29915766 |
| 42 | * Endometrial cancer_Homo sapiens_hsa05213 | 1.28126744 |
| 43 | * Glioma_Homo sapiens_hsa05214 | 1.26656218 |
| 44 | * Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.25380577 |
| 45 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.24479037 |
| 46 | * AMPK signaling pathway_Homo sapiens_hsa04152 | 1.21971342 |
| 47 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.20844251 |
| 48 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.18984249 |
| 49 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.16901768 |
| 50 | * T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.15845362 |
| 51 | * Osteoclast differentiation_Homo sapiens_hsa04380 | 1.15362907 |
| 52 | * Choline metabolism in cancer_Homo sapiens_hsa05231 | 1.13850564 |
| 53 | * Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 1.11548002 |
| 54 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.10581967 |
| 55 | * Hepatitis C_Homo sapiens_hsa05160 | 1.09012399 |
| 56 | * Prostate cancer_Homo sapiens_hsa05215 | 1.08714160 |
| 57 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 1.07526540 |
| 58 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 1.05651743 |
| 59 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.05102015 |
| 60 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.04681745 |
| 61 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.04342562 |
| 62 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.03702834 |
| 63 | * Hepatitis B_Homo sapiens_hsa05161 | 1.02379766 |
| 64 | * Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.02344354 |
| 65 | * Insulin signaling pathway_Homo sapiens_hsa04910 | 1.01822668 |
| 66 | * Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.99853208 |
| 67 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.98221391 |
| 68 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.97235156 |
| 69 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.97198224 |
| 70 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.94681941 |
| 71 | * FoxO signaling pathway_Homo sapiens_hsa04068 | 0.93652065 |
| 72 | Bile secretion_Homo sapiens_hsa04976 | 0.93575158 |
| 73 | * TNF signaling pathway_Homo sapiens_hsa04668 | 0.92961518 |
| 74 | * Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.89754461 |
| 75 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.89235968 |
| 76 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.87853843 |
| 77 | * Colorectal cancer_Homo sapiens_hsa05210 | 0.87072448 |
| 78 | * Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.86610197 |
| 79 | * HTLV-I infection_Homo sapiens_hsa05166 | 0.86136138 |
| 80 | * Toxoplasmosis_Homo sapiens_hsa05145 | 0.84724859 |
| 81 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.83073967 |
| 82 | Leishmaniasis_Homo sapiens_hsa05140 | 0.81571955 |
| 83 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.81030910 |
| 84 | * Influenza A_Homo sapiens_hsa05164 | 0.80636776 |
| 85 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.79012435 |
| 86 | Sulfur relay system_Homo sapiens_hsa04122 | 0.75918692 |
| 87 | * MAPK signaling pathway_Homo sapiens_hsa04010 | 0.75254261 |
| 88 | * Apoptosis_Homo sapiens_hsa04210 | 0.73465179 |
| 89 | Long-term potentiation_Homo sapiens_hsa04720 | 0.72923669 |
| 90 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.71146293 |
| 91 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.70515638 |
| 92 | * Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.69434543 |
| 93 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.68567941 |
| 94 | * Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.67311756 |
| 95 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.66479786 |
| 96 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.66074809 |
| 97 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.65668644 |
| 98 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.64055703 |
| 99 | ABC transporters_Homo sapiens_hsa02010 | 0.63994020 |
| 100 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.63384537 |
| 101 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.62962085 |
| 102 | * Measles_Homo sapiens_hsa05162 | 0.62333792 |
| 103 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.60935259 |
| 104 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.60755209 |
| 105 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.60196532 |
| 106 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.58953709 |
| 107 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.58667269 |
| 108 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.57834077 |
| 109 | Endocytosis_Homo sapiens_hsa04144 | 0.57428720 |
| 110 | * Focal adhesion_Homo sapiens_hsa04510 | 0.57346784 |
| 111 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.56503668 |
| 112 | * Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.56458249 |
| 113 | Viral myocarditis_Homo sapiens_hsa05416 | 0.55098228 |
| 114 | * Platelet activation_Homo sapiens_hsa04611 | 0.54954803 |
| 115 | * Pathways in cancer_Homo sapiens_hsa05200 | 0.54230796 |
| 116 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.54183116 |
| 117 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.53391499 |
| 118 | * Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.53294241 |
| 119 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.53142436 |
| 120 | * Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.48885738 |
| 121 | * Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.48824283 |
| 122 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.48639765 |
| 123 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.47759050 |
| 124 | * Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.47006877 |
| 125 | * Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.44454324 |
| 126 | Histidine metabolism_Homo sapiens_hsa00340 | 0.44029068 |
| 127 | Retinol metabolism_Homo sapiens_hsa00830 | 0.42083039 |
| 128 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.41516003 |
| 129 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.40178240 |
| 130 | * mTOR signaling pathway_Homo sapiens_hsa04150 | 0.39805904 |
| 131 | Galactose metabolism_Homo sapiens_hsa00052 | 0.39423969 |
| 132 | * Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.39010035 |
| 133 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.38626133 |
| 134 | * Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.36646588 |
| 135 | Amoebiasis_Homo sapiens_hsa05146 | 0.36091394 |
| 136 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.35110178 |
| 137 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.35106386 |
| 138 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.32961398 |
| 139 | Bladder cancer_Homo sapiens_hsa05219 | 0.32496543 |
| 140 | * Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.31968812 |
| 141 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.30540302 |
| 142 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.28289279 |
| 143 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.27085322 |
| 144 | Adherens junction_Homo sapiens_hsa04520 | 0.26062587 |
| 145 | * AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.24447064 |
| 146 | Circadian rhythm_Homo sapiens_hsa04710 | 0.23727333 |
| 147 | * Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.22888528 |
| 148 | * Small cell lung cancer_Homo sapiens_hsa05222 | 0.21065191 |
| 149 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.20873214 |
| 150 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.18159140 |
| 151 | * HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.17770463 |
| 152 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.17495425 |
| 153 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.17484994 |
| 154 | Prion diseases_Homo sapiens_hsa05020 | 0.17400408 |
| 155 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.17288819 |
| 156 | * Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.16531247 |
| 157 | * VEGF signaling pathway_Homo sapiens_hsa04370 | 0.16154252 |
| 158 | * cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.15608976 |
| 159 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.15406160 |
| 160 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.15353731 |

